Item Type | Name |
Academic Article
|
Tacrolimus rescue therapy for renal transplant rejection.
|
Academic Article
|
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
|
Academic Article
|
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.
|
Academic Article
|
Tolerogenic immunosuppression for organ transplantation.
|
Academic Article
|
Non-lymphoid cancer after liver transplantation.
|
Academic Article
|
Small bowel transplantation: current progress and clinical application.
|
Academic Article
|
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
|
Academic Article
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report.
|
Academic Article
|
Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model.
|
Academic Article
|
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
|
Academic Article
|
Tacrolimus rescue therapy for renal allograft rejection--five-year experience.
|
Academic Article
|
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
|
Academic Article
|
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus.
|
Academic Article
|
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
|
Academic Article
|
Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
|
Academic Article
|
Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
|
Academic Article
|
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
|
Academic Article
|
State of immunosuppressive agents in organ transplantation.
|
Academic Article
|
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
|
Academic Article
|
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
|
Academic Article
|
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
|
Academic Article
|
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.
|
Academic Article
|
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
|
Academic Article
|
Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
|
Academic Article
|
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.
|
Academic Article
|
Weaning of immunosuppression in liver transplant recipients.
|
Academic Article
|
Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity.
|
Academic Article
|
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia.
|
Academic Article
|
Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients.
|
Academic Article
|
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results.
|
Academic Article
|
Patient participation in research among solid organ transplant recipients in the United States.
|
Academic Article
|
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection.
|
Academic Article
|
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
|
Academic Article
|
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft.
|
Academic Article
|
Central venulitis in the allograft liver: a clinicopathologic study.
|
Academic Article
|
Outcome of kidney transplantation in African-Americans using tacrolimus.
|
Academic Article
|
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
|
Academic Article
|
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
|
Academic Article
|
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature.
|
Academic Article
|
FK506 in solid organ transplantation.
|
Academic Article
|
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model.
|
Academic Article
|
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.
|
Academic Article
|
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
|
Academic Article
|
Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
|
Academic Article
|
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management.
|
Academic Article
|
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival.
|
Academic Article
|
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
|
Academic Article
|
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up.
|
Academic Article
|
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
|
Academic Article
|
Rapamycin: friend, foe, or misunderstood?
|
Academic Article
|
The long-term efficacy of multivisceral transplantation.
|
Academic Article
|
Five-year experience with tacrolimus rescue for renal allograft rejection.
|
Academic Article
|
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
|
Academic Article
|
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation.
|
Academic Article
|
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.
|
Academic Article
|
Kaposi's sarcoma in liver transplant recipients on FK506.
|
Academic Article
|
Tacrolimus and transplantation: a decade in review.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Academic Article
|
Immunosuppressive therapy.
|
Academic Article
|
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation.
|
Academic Article
|
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
|
Academic Article
|
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
|
Academic Article
|
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model.
|
Academic Article
|
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
|
Academic Article
|
Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease.
|
Academic Article
|
Reversal of acute cellular rejection after renal transplantation with Campath-1H.
|
Academic Article
|
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts.
|
Academic Article
|
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
|
Academic Article
|
Immunosuppression in liver transplantation: beyond calcineurin inhibitors.
|
Academic Article
|
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
|
Academic Article
|
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients.
|
Academic Article
|
Cardiac operations in solid-organ transplant recipients.
|
Academic Article
|
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial.
|
Academic Article
|
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
|
Academic Article
|
Prolonged survival of heart allografts transduced with AAV-CTLA4Ig.
|
Academic Article
|
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
|
Academic Article
|
Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
|
Academic Article
|
Clinical intestinal transplantation: new perspectives and immunologic considerations.
|
Academic Article
|
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Future prospects in immunosuppression for liver transplantation.
|
Academic Article
|
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.
|
Academic Article
|
Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
|
Academic Article
|
Randomised trialomania? The multicentre liver transplant trials of tacrolimus.
|
Academic Article
|
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
|
Academic Article
|
Pregnancy after liver transplantation under tacrolimus.
|
Academic Article
|
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.
|
Academic Article
|
Two-year experience with FK 506 in pediatric patients.
|
Academic Article
|
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
|
Academic Article
|
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin.
|
Academic Article
|
Current status of intestinal transplantation in children.
|
Academic Article
|
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.
|
Academic Article
|
Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway.
|
Academic Article
|
De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature.
|
Academic Article
|
Alopecia as a consequence of tacrolimus therapy.
|
Academic Article
|
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
|
Academic Article
|
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.
|
Academic Article
|
Cytidine potentiates the inhibitory effect of brequinar sodium on xeno-MLR, antibody production, and concordant hamster to rat cardiac xenograft survival.
|
Academic Article
|
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Academic Article
|
Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.
|
Academic Article
|
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.
|
Academic Article
|
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
|
Academic Article
|
Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era.
|
Academic Article
|
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies.
|
Academic Article
|
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.
|
Academic Article
|
Tacrolimus for rescue of refractory renal allograft rejection.
|
Academic Article
|
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.
|
Academic Article
|
Immunosuppression: evolution in practice and trends, 1994-2004.
|
Academic Article
|
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
|
Academic Article
|
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.
|
Academic Article
|
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.
|
Academic Article
|
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.
|
Academic Article
|
Present state of immunosuppressive therapy in liver transplant recipients.
|
Academic Article
|
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
|
Academic Article
|
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
|
Academic Article
|
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
|
Academic Article
|
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
|
Academic Article
|
Weaning of immunosuppression in long-term liver transplant recipients.
|
Academic Article
|
Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft.
|
Academic Article
|
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.
|
Academic Article
|
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience.
|
Academic Article
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report.
|
Academic Article
|
Long-term results of pancreas transplantation under tacrolius immunosuppression.
|
Academic Article
|
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.
|
Academic Article
|
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
|
Academic Article
|
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.
|
Academic Article
|
Role of splenectomy in human liver transplantation under modern-day immunosuppression.
|
Academic Article
|
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
|
Academic Article
|
Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
|
Academic Article
|
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
|
Academic Article
|
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
|
Academic Article
|
Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation.
|
Academic Article
|
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.
|
Academic Article
|
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
|
Academic Article
|
FK 506 dosage in human organ transplantation.
|
Academic Article
|
Studies of the hepatotrophic qualities of FK 506 and CyA.
|
Academic Article
|
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy.
|
Academic Article
|
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
|
Academic Article
|
Use of FK 506 in pediatric patients.
|
Academic Article
|
The side effects of FK 506 in humans.
|
Academic Article
|
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
|
Academic Article
|
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients.
|
Academic Article
|
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.
|
Academic Article
|
Assay of FK 506 in plasma.
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
|
Academic Article
|
Effects of in vivo treatment with FK506 on natural killer cells in rats.
|
Academic Article
|
Posttransplant diabetes in pediatric recipients on tacrolimus.
|
Academic Article
|
Liver transplantation in patients with HIV infection.
|
Academic Article
|
Infectious complications after human small bowel transplantation.
|
Academic Article
|
Infections with FK 506 immunosuppression: preliminary results with primary therapy.
|
Academic Article
|
Pharmacokinetics of FK 506: preclinical and clinical studies.
|
Academic Article
|
Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine.
|
Academic Article
|
Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report.
|
Academic Article
|
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models.
|
Academic Article
|
Oral glucose tolerance test in liver recipients treated with FK 506.
|
Academic Article
|
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.
|
Academic Article
|
Liver, kidney, and thoracic organ transplantation under FK 506.
|
Academic Article
|
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
|
Academic Article
|
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
|
Academic Article
|
Loss of serum bicarbonate after discordant liver xenotransplantation.
|
Academic Article
|
Pathologic observations in human allograft recipients treated with FK 506.
|
Academic Article
|
Liver transplantation under cyclosporine: a decade of experience.
|
Academic Article
|
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus.
|
Academic Article
|
High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
|
Academic Article
|
William Hunter Harridge lecture: The changing face of short-gut syndrome management.
|
Academic Article
|
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
|
Academic Article
|
Limitations of current liver transplant immunosuppressive regimens: renal considerations.
|
Academic Article
|
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression.
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
|
Academic Article
|
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial.
|